Nipah virus (NiV) causes the deadly viral zoonotic infectious disease called Nipah, that can transmit from animals to humans.
Animals such as bats, most commonly the fruit bats called as flying fox and pigs were the acting carriers of Niv.
Nipah viral infection in humans results in range of clinical presentations such as asymptomatic infection (subclinical) to acute respiratory infection and fatal encephalitis.
This infection has about 40 to 75% fatality rate, which can be varied depending on the local capabilities for epidemiological surveillance and clinical management.
Presently approved treatment or vaccination is unavailable for infected rather than supportive care.
Therefore, the disease calls out for an urgent need for an approved treatment regimen for a proper cure of the disease. As stated by the 2018 annual review of the WHO R&D Blueprint list of priority diseases.
Nipah virus (NiV) causes the deadly viral zoonotic infectious disease called Nipah, that
can transmit from animals to humans.
• Animals such as bats, most commonly the fruit bats called as flying fox and pigs were
the acting carriers of Niv.
• Nipah viral infection in humans results in range of clinical presentations such as
asymptomatic infection (subclinical) to acute respiratory infection and fatal
encephalitis.
• This infection has about 40 to 75% fatality rate, which can be varied depending on
the local capabilities for epidemiological surveillance and clinical management.
• Presently approved treatment or vaccination is unavailable for infected rather than
supportive care.
• Therefore, the disease calls out for an urgent need for an approved treatment
regimen for a proper cure of the disease. As stated by the 2018 annual review of the
WHO R&D Blueprint list of priority diseases.
Brief information about nipah virus infection and more emphasis on factors responsible for emergence of disease in India and prevention & control strategies relevant to Indian conditions.
The first step in preventive health is to be aware and to be prepared. Recently, the Nipah Virus has been detected
in parts of India, and given the seriousness of the illness, it is best to be informed and aware.
1. What Is the Nipah Virus?
2. Symptoms
3. Preventive Measures & Infection Control
Nipah virus : New emerging disease with high mortality Harivansh Chopra
Nipah Virus is one of the emerging viral infection with high mortality. Can be prevented by simply using hand washing and by good food and fruit hygiene, Still no vaccine is available for human although trials are underway. Ribavarin can be used for treatment with variable results. Prevention is still the best method for treatment. Strong IEC is required for effective prevention.
Nipah Virus: All You Need To Know About This Deadly Virus|Nipah Virus ExplainedMD SAMIR UDDIN
All You Need To Know About This Deadly Virus called Nipah virus
Nipah Virus is an emerging infectious disease that broke out in Malaysia and Singapore in 1998 and 1999. It first appeared in domestic pigs and has been found among several species of domestic animals including dogs, cats, goats, horses and sheep. The infection is also known to affect human beings. The organism which causes Nipah Virus encephalitis is an RNA or Ribonucleic acid virus of the family Paramyxoviridae, genus Henipavirus, and is closely related to Hendra virus.
Nipah Virus Explained by SAMIR UDDIN Consultacy
Nipah virus (NiV) causes the deadly viral zoonotic infectious disease called Nipah, that
can transmit from animals to humans.
• Animals such as bats, most commonly the fruit bats called as flying fox and pigs were
the acting carriers of Niv.
• Nipah viral infection in humans results in range of clinical presentations such as
asymptomatic infection (subclinical) to acute respiratory infection and fatal
encephalitis.
• This infection has about 40 to 75% fatality rate, which can be varied depending on
the local capabilities for epidemiological surveillance and clinical management.
• Presently approved treatment or vaccination is unavailable for infected rather than
supportive care.
• Therefore, the disease calls out for an urgent need for an approved treatment
regimen for a proper cure of the disease. As stated by the 2018 annual review of the
WHO R&D Blueprint list of priority diseases.
Brief information about nipah virus infection and more emphasis on factors responsible for emergence of disease in India and prevention & control strategies relevant to Indian conditions.
The first step in preventive health is to be aware and to be prepared. Recently, the Nipah Virus has been detected
in parts of India, and given the seriousness of the illness, it is best to be informed and aware.
1. What Is the Nipah Virus?
2. Symptoms
3. Preventive Measures & Infection Control
Nipah virus : New emerging disease with high mortality Harivansh Chopra
Nipah Virus is one of the emerging viral infection with high mortality. Can be prevented by simply using hand washing and by good food and fruit hygiene, Still no vaccine is available for human although trials are underway. Ribavarin can be used for treatment with variable results. Prevention is still the best method for treatment. Strong IEC is required for effective prevention.
Nipah Virus: All You Need To Know About This Deadly Virus|Nipah Virus ExplainedMD SAMIR UDDIN
All You Need To Know About This Deadly Virus called Nipah virus
Nipah Virus is an emerging infectious disease that broke out in Malaysia and Singapore in 1998 and 1999. It first appeared in domestic pigs and has been found among several species of domestic animals including dogs, cats, goats, horses and sheep. The infection is also known to affect human beings. The organism which causes Nipah Virus encephalitis is an RNA or Ribonucleic acid virus of the family Paramyxoviridae, genus Henipavirus, and is closely related to Hendra virus.
Nipah Virus Explained by SAMIR UDDIN Consultacy
Nipah virus is an newly out broke virus from the animal species the exact reason for the virus out bake was not
known clearly some scientist are concluded the point regarding the reoccurrence of the virus in the India after a gap
of 8 years of last impact, this virus is mainly spreading because of the a kind of the cattle pigs and from the infected
fruit bat. At first virus has been found in the region of the south East Asia islands later few developed countries has
taken a step forward in order to control or eradicate the virus while few countries has left the solution for the
problem. Recently a week back the virus has been observed in the south state of the India. As it was known fact that
this virus is a zoonosis. Various countries are a step ahead in the research. When compared to the west part of the
world the impact of the disease is more in the eastern part of the world. There is no particular vaccination for this
virus, diagnosis for the disease is also a complex task.
nipah virus is an dangerous infection , there is no treatment available for this currently only intensive treatment is given , its epidemiology show 75% of death rate.
here is the brief information about the nipah virus infection (NiV).
Nipah Virus (NiV) is a negative sense, single stranded, enveloped RNA virus.
Zoonotic virus
Family – Paramyxoviridae
Genus - Henipavirus
It is a BSL-4 pathogen.
The name "Nipah" refers to the place, Sungai Nipah (literally 'nipah river') in Malaysia, the source of the human case from which Nipah virus was first isolated.Nipah virus can remain viable for a few days in few fruit juices or mango fruits, and at least 7 days in palm milk.
Bats act as a breeding ground for many dangerous viruses, including Nipah, rabies, and Marburg viruses. Such viruses are not associated with any major pathological changes within the bat population.
Transmission of NiV occurs by eating contaminated food. Risks include contact, touch, breastfeeding, or exposure to an infected person, thereby making it easier to come in contact with a droplet of NiV infection.
More recently, experimental studies with aerosolized NiV in Syrian hamsters have found that NiV droplets (aerosol distribution) may cause NiV transmission during close contact. Drinking fresh palm milk is a very common method, and the use of Tari (ripe palm juice) is a powerful way to transmit the virus.
Breast Cancer Awareness Month has
been celebrated every October for the
last 90 years. It is called as “Pink
October” as people around the world
adopt the color pink and display a pink
ribbon to raise awareness about the
importance of prevention and routine
screening for the early diagnosis of
breast cancer.The theme for Breast Cancer
Awareness Month, 2023 is 'Keeping
Her in the Picture'
, a plea to everyone
to keep an eye on the well-being of the
significant women in their lives.
Bloating is a condition where your belly feels full and tight, often due to gas.
People might confuse bloating with other reasons for a more noticeable belly, such as abdominal wall laxity, or looseness. This is common, especially among older women and those who have had children.
It's important to know the difference so you can get the right treatment. A toned abdomen can make it easier to see a difference when the gut is full of food or stool.
Nipah virus is an newly out broke virus from the animal species the exact reason for the virus out bake was not
known clearly some scientist are concluded the point regarding the reoccurrence of the virus in the India after a gap
of 8 years of last impact, this virus is mainly spreading because of the a kind of the cattle pigs and from the infected
fruit bat. At first virus has been found in the region of the south East Asia islands later few developed countries has
taken a step forward in order to control or eradicate the virus while few countries has left the solution for the
problem. Recently a week back the virus has been observed in the south state of the India. As it was known fact that
this virus is a zoonosis. Various countries are a step ahead in the research. When compared to the west part of the
world the impact of the disease is more in the eastern part of the world. There is no particular vaccination for this
virus, diagnosis for the disease is also a complex task.
nipah virus is an dangerous infection , there is no treatment available for this currently only intensive treatment is given , its epidemiology show 75% of death rate.
here is the brief information about the nipah virus infection (NiV).
Nipah Virus (NiV) is a negative sense, single stranded, enveloped RNA virus.
Zoonotic virus
Family – Paramyxoviridae
Genus - Henipavirus
It is a BSL-4 pathogen.
The name "Nipah" refers to the place, Sungai Nipah (literally 'nipah river') in Malaysia, the source of the human case from which Nipah virus was first isolated.Nipah virus can remain viable for a few days in few fruit juices or mango fruits, and at least 7 days in palm milk.
Bats act as a breeding ground for many dangerous viruses, including Nipah, rabies, and Marburg viruses. Such viruses are not associated with any major pathological changes within the bat population.
Transmission of NiV occurs by eating contaminated food. Risks include contact, touch, breastfeeding, or exposure to an infected person, thereby making it easier to come in contact with a droplet of NiV infection.
More recently, experimental studies with aerosolized NiV in Syrian hamsters have found that NiV droplets (aerosol distribution) may cause NiV transmission during close contact. Drinking fresh palm milk is a very common method, and the use of Tari (ripe palm juice) is a powerful way to transmit the virus.
Breast Cancer Awareness Month has
been celebrated every October for the
last 90 years. It is called as “Pink
October” as people around the world
adopt the color pink and display a pink
ribbon to raise awareness about the
importance of prevention and routine
screening for the early diagnosis of
breast cancer.The theme for Breast Cancer
Awareness Month, 2023 is 'Keeping
Her in the Picture'
, a plea to everyone
to keep an eye on the well-being of the
significant women in their lives.
Bloating is a condition where your belly feels full and tight, often due to gas.
People might confuse bloating with other reasons for a more noticeable belly, such as abdominal wall laxity, or looseness. This is common, especially among older women and those who have had children.
It's important to know the difference so you can get the right treatment. A toned abdomen can make it easier to see a difference when the gut is full of food or stool.
Coronavirus disease 2019 (COVID-19) pandemic has a catastrophic impact on human
health.1 They cause the severe acute respiratory syndrome, leading to a significant
increase in morbidity and mortality worldwide.2 In addition to ample vaccine
availability for mitigating COVID-19, there is an urgency for an effective, easily
compatible antiviral drug. Although antivirals like Ramdesivir and Favipiravir was
tried in the early pandemic, yet it failed to exhibit the expected potency.2,3
Basics of Molnupiravir:
It is an isopropyl ester prodrug initially developed by Emory inventory. Later the
same was acquired by Merck and Ridgeback partnership.4 So far, the antivirals
terminated the elongation of RNA-chain by targeting the viral polymerase, which was
not a promising treatment of SARS-CoV-2 infections. They also had a limitation in
their administration. Whereas molnupiravir, the so-called magic pill, is an exceptional
drug with a unique error catastrophic mechanism that advances in increasing the rate
of mutation in the viral genome, outweighing the
As per a study (Sizar et al., 2021), Vitamin D deficiency (VDD) is highly prevalent among
more than one billion people worldwide. Vitamin D is of 2 types vitamin D3 and vitamin D2;
It is a prohormone and has a significant role in controlling calcium and phosphorus
metabolism. It also has anti-inflammatory, antioxidant, and anti-proliferative functions in
various parts of our body. VDD is a common symptom in most chronic and severe diseases
such as cancer (prostate, breast, and colon cancer), mental disorders, asthma, diabetic
retinopathy, infectious, autoimmune, and cardiovascular diseases. In children, VDD is linked
to detrimental defects such as rickets, dental caries, growth failure, and premature death.
VDD increases the risk of preeclampsia in pregnant women, which results in the need for a
cesarean section. Pregnant, lactating, dark-toned (highly melanin pigmented), obese
children and children and adults who abstained from direct sun exposure are at high risk of
VDD. Consequentially use of sunscreen, season, altitude, latitude, time of the day, and
clothing influence the sun-induced synthesis of vitamin D3 in the skin. UV-B and some UV-A
radiation are absorbed by sunscreen, thus preventing it from reaching the skin and leading
to VDD.
Monkeypox is derived from the genus Orthopoxvirus from the family Poxividae. This
genus has two kinds of viruses: smallpox and monkeypox virus. Monkeypox is a
zoonotic disease (spread from animal to human or vice versa) and was initially
diagnosed with pox-like symptoms on colonies of monkeys kept for research in 1958,
hence the name monkeypox. At the time of the elimination of smallpox in 1970,
monkeypox in humans was first identified in the Democratic Republic of Congo and
later in Central and Western African countries.1,2 In 2019, a newer vaccinia vaccine
was approved to prevent the disease. Furthermore, investigations are still carried out
on the same.
Animal-to-human (zoonotic) transmission can occur from direct contact with
infected animals' blood, bodily fluids, or cutaneous or mucosal lesions. In Africa,
evidence of monkeypox virus infection has been found in many animals, including
rope squirrels, tree squirrels, Gambian pouched rats, dormice, different species of
monkeys, and others. It was also found that eating improperly/half-cooked meat is
also a cause. The disease spread outside Africa by infected travellers and imported
infected animals. In 2018-2019, cases of monkeypox were confirmed in travellers
from Nigeria, Singapore, the United Kingdom, and Israel. Human-to-human
transmission can result from close contact with respiratory secretions and lesions of
the skin.3
Risk groups include people with severe illnesses who require hospitalization or an
immune-compromised person (HIV, leukaemia, etc); patients with comorbidities, a
pediatric population less than eight years old, and pregnant or breastfeeding women.2
The incubation period is generally 6-13 days, but it can range from 5-21 days. The
disease progression has two phases: The invasive phase (0-5 days), characterized by
headache, fever, back pain, myalgia, fatigue and lymphadenopathy. The rash
appearing phase (1-3 days) begins after the onset of the first phase and is
characterized by the appearance of rashes on the face and then spreads up to the
trunk and limbs of the body. Rashes evolve from macules (flat base lesions) to papules
(firm lesions), then vesicles (clear fluid- filled lesions), and finally postulates
(yellowish fluid-filled lesions) and crusts. It affects the face (in 95% of cases), palms
of the hands, and soles of the feet (in 75% of cases). Also affected were oral mucous
membranes (in 70% of cases), genitalia (30%), conjunctivae (20%), as well as cornea.
Complications of monkeypox include pneumonitis, encephalitis, sight-threatening
keratitis, and secondary bacterial infections.3,4
“Pharmacy strengthening health
systems” is the theme of World
Pharmacists Day on 25 September
This subject basically emphasises how crucial pharmacy is to maintaining and
strengthening the healthcare system for the benefit of people and communities
across the globe.
History of World Pharmacist Day
At the 2009 International Pharmaceutical Federation (FIP) Congress in
Istanbul, Turkey, the notion of a global pharmacist day was created. The FIP
Council selected pharmacy leaders from across the world and endorsed World
Pharmacists Day on September 25.
The Week is an initiative of the Global Alliance to Eliminate Lead Paint (Lead Paint
Alliance), which is jointly led by the UN Environment Programme (UNEP) and World
Health Organization (WHO). It takes place annually in October. International Lead
Poisoning Prevention Week 2023 takes place from 22-28 October.
The week of action aims to draw attention to the health impacts of lead exposure,
highlight efforts by countries and partners to prevent childhood lead exposure, and
accelerate efforts to phase out the use of lead in paint and paint products in future.
#leadpoisoning
Air pollution is a familiar environmental health hazard. We know what we’re looking at
when brown haze settles over a city, exhaust billows across a busy highway, or a plume
rises from a smokestack. Some air pollution is not seen, but its pungent smell alerts you.
It is a major threat to global health and prosperity. Air pollution, in all forms, is responsible
for more than 6.5 million deaths each year globally, a number that has increased over the
past two decades.
Air pollution is a mix of hazardous substances from both human-made and natural sources.
Vehicle emissions, fuel oils and natural gas to heat homes, by-products of manufacturing
and power generation, particularly coal-fueled power plants, and fumes from chemical
production are the primary sources of human-made air pollution.
Nature releases hazardous substances into the air, such as smoke from wildfires, which are
often caused by people; ash and gases from volcanic eruptions; and gases, like methane,
which are emitted from decomposing organic matter in soils.
Bloating is a condition where your belly feels full and tight, often due to gas.
People might confuse bloating with other reasons for a more noticeable belly, such as abdominal wall laxity, or looseness. This is common, especially among older women and those who have had children.
It's important to know the difference so you can get the right treatment. A toned abdomen can make it easier to see a difference when the gut is full of food or stool.
Breast Cancer Awareness Month has
been celebrated every October for the
last 90 years. It is called as “Pink
October” as people around the world
adopt the color pink and display a pink
ribbon to raise awareness about the
importance of prevention and routine
screening for the early diagnosis of
breast cancer.
The theme for Breast Cancer
Awareness Month, 2023 is 'Keeping
Her in the Picture'
, a plea to everyone
to keep an eye on the well-being of the
significant women in their lives.
Nipah virus (Niv) is a zoonotic virus that can spread between animals and people. Fruit bats, also called flying foxes, are the NIV reservoir among animals in nature. Spread of disease occurs from the infected fruit bats to other animals, such as pigs, and from infected animals to humans. The infection occurs through contaminated fruits by the animal's body fluids such as saliva, urine, or blood. Therefore, the initial spread is from animals to humans and then within humans.
Thus, the infection caused by Niv results in milder to severe illness ranging from acute respiratory tract infection to severe brain encephalitis (swelling of the brain). The Nipah outbreaks were most commonly observed in parts of Asia, primarily India and Bangladesh. This outbreak reported 40-75% of deaths in 1998 and 2018.
Past outbreaks
Nipah virus (NiV) was first identified in Malaysia and Singapore following an outbreak of disease in pigs and people in 1999. This outbreak resulted in more than 100 deaths and nearly 300 infected cases in people. More than a million pigs were killed to control further outbreaks of disease, and there have been no outbreaks in both countries since 1999.
In 2001, an annual outbreak of the disease was observed in Bangladesh. It was also periodically identified in India. The quick spread of the virus from animals to humans raised concern about NIV and made it a global pandemic.
Transmission
The first known outbreak in Singapore and Malaysia was through direct contact with the Nipah (Niv) infected pigs or their body fluids. It identified that the infected pigs got the Niv strain from bats, which subsequently resulted in transmission of the viral strains from pigs to humans by their unprotected exposure to infected animal species, which in turn led to a severe health issue in contact with humans that was even fatal due to unavailability of proper medications or vaccinations. There was no report of person-person transmission of disease in the outbreak.
Whereas person-person transmission was first reported in India (2001) and Bangladesh (2001-2008) by consumption of fruits and vegetables contaminated by the body fluids of infected animals caused Nipah virus infection.
The spread of the Nipah virus (NiV) from people was through the following causes:
• Direct contact with infected animals or their body fluids (such as bats or pigs).
• Consumption of fruits or vegetables contaminated by the body fluids of infected animals (such as palm sap).
• Close or direct contact with Niv infected person infected their body fluids (such as nasal droplets, blood, or urine).
Signs and Symptoms
The symptoms commonly appear 4-14 days after exposure to the virus. However, in many cases incubation period as long as 45 days has been reported.
Symptoms may initially include one or several of the following for 3-14days:
• Fever
• Headache
• Vomiting
Signs of respiratory illness:
• Sore throat
• Cough
• Difficulty breathing
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERYNEHA GUPTA
The process of drug discovery and development is a complex and multi-step endeavor aimed at bringing new pharmaceutical drugs to market. It begins with identifying and validating a biological target, such as a protein, gene, or RNA, that is associated with a disease. This step involves understanding the target's role in the disease and confirming that modulating it can have therapeutic effects. The next stage, hit identification, employs high-throughput screening (HTS) and other methods to find compounds that interact with the target. Computational techniques may also be used to identify potential hits from large compound libraries.
Following hit identification, the hits are optimized to improve their efficacy, selectivity, and pharmacokinetic properties, resulting in lead compounds. These leads undergo further refinement to enhance their potency, reduce toxicity, and improve drug-like characteristics, creating drug candidates suitable for preclinical testing. In the preclinical development phase, drug candidates are tested in vitro (in cell cultures) and in vivo (in animal models) to evaluate their safety, efficacy, pharmacokinetics, and pharmacodynamics. Toxicology studies are conducted to assess potential risks.
Before clinical trials can begin, an Investigational New Drug (IND) application must be submitted to regulatory authorities. This application includes data from preclinical studies and plans for clinical trials. Clinical development involves human trials in three phases: Phase I tests the drug's safety and dosage in a small group of healthy volunteers, Phase II assesses the drug's efficacy and side effects in a larger group of patients with the target disease, and Phase III confirms the drug's efficacy and monitors adverse reactions in a large population, often compared to existing treatments.
After successful clinical trials, a New Drug Application (NDA) is submitted to regulatory authorities for approval, including all data from preclinical and clinical studies, as well as proposed labeling and manufacturing information. Regulatory authorities then review the NDA to ensure the drug is safe, effective, and of high quality, potentially requiring additional studies. Finally, after a drug is approved and marketed, it undergoes post-marketing surveillance, which includes continuous monitoring for long-term safety and effectiveness, pharmacovigilance, and reporting of any adverse effects.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Antimicrobial stewardship to prevent antimicrobial resistanceGovindRankawat1
India is among the nations with the highest burden of bacterial infections.
India is one of the largest consumers of antibiotics worldwide.
India carries one of the largest burdens of drug‑resistant pathogens worldwide.
Highest burden of multidrug‑resistant tuberculosis,
Alarmingly high resistance among Gram‑negative and Gram‑positive bacteria even to newer antimicrobials such as carbapenems.
NDM‑1 ( New Delhi Metallo Beta lactamase 1, an enzyme which inactivates majority of Beta lactam antibiotics including carbapenems) was reported in 2008
ABDOMINAL TRAUMA in pediatrics part one.drhasanrajab
Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
2. Key facts
• Nipah virus (NiV) causes the deadly viral zoonotic infectious disease called Nipah, that can transmit from
animals to humans.
• Animals such as bats, most commonly the fruit bats called as flying fox and pigs were the acting carriers of
Niv.
• Nipah viral infection in humans results in range of clinical presentations such as asymptomatic infection
(subclinical) to acute respiratory infection and fatal encephalitis.
• This infection has about 40 to 75% fatality rate, which can be varied depending on the local capabilities for
epidemiological surveillance and clinical management.
• Presently approved treatment or vaccination is unavailable for infected rather than supportive care.
• Therefore, the disease calls out for an urgent need for an approved treatment regimen for a proper cure of
the disease. As stated by the 2018 annual review of the WHO R&D Blueprint list of priority diseases.
3. What is Nipah Virus?
Nipah virus (Niv) is a zoonotic virus that can spread between animals and people.
Fruit bats, also called flying foxes, are the NIV reservoir among animals in nature.
Spread of disease occurs from the infected fruit bats to other animals, such as pigs,
and from infected animals to humans. The infection occurs through contaminated
fruits by the animal's body fluids such as saliva, urine, or blood. Therefore, the initial
spread is from animals to humans and then within humans.
Thus, the infection caused by Niv results in milder to severe illness ranging from
acute respiratory tract infection to severe brain encephalitis (swelling of the brain).
The Nipah outbreaks were most commonly observed in parts of Asia, primarily
India and Bangladesh. This outbreak reported 40-75% of deaths in 1998 and 2018.
4. Past outbreaks
Nipah virus (NiV) was first identified in Malaysia and Singapore following an outbreak of disease in
pigs and people in 1999. This outbreak resulted in more than 100 deaths and nearly 300 infected
cases in people. More than a million pigs were killed to control further outbreaks of disease, and
there have been no outbreaks in both countries since 1999.
In 2001, an annual outbreak of the disease was observed in Bangladesh. It was also periodically
identified in India. The quick spread of the virus from animals to humans raised concern about NIV
and made it a global pandemic.
5. Transmission
The first known outbreak in Singapore and Malaysia was through direct contact with the Nipah
(Niv) infected pigs or their body fluids. It identified that the infected pigs got the Niv strain from
bats, which subsequently resulted in transmission of the viral strains from pigs to humans by their
unprotected exposure to infected animal species, which in turn led to a severe health issue in
contact with humans that was even fatal due to unavailability of proper medications or
vaccinations. There was no report of person-person transmission of disease in the outbreak.
Whereas person-person transmission was first reported in India (2001) and Bangladesh (2001-2008)
by consumption of fruits and vegetables contaminated by the body fluids of infected animals
caused Nipah virus infection.
6. The spread of the Nipah virus (NiV) from people was through the following causes:
• Direct contact with infected animals or their body fluids (such as bats or pigs).
• Consumption of fruits or vegetables contaminated by the body fluids of infected animals (such
as palm sap).
• Close or direct contact with Niv infected person infected their body fluids (such as nasal
droplets, blood, or urine).
7. Signs and Symptoms
Symptoms may initially include one or several of the following for 3-14days:
• Fever
• Headache
• Vomiting
Signs of respiratory illness:
• Sore throat
• Cough
• Difficulty breathing
In the later phase, brain encephalitis with the following symptoms observed within 24-48 hours:
• Disorientation, drowsiness, or mental confusion
• Seizures
• Coma
8. Approximately 20% of patients have residual neurological consequences such as personality
changes and seizure disorders. Chances of relapse or developing delayed onset encephalitis are
most common in cured persons.
An estimated rate of 40% to 75% of fatality cases was reported. The rate can vary depending on
local capabilities for epidemiological surveillance and clinical management of the outbreak.
9. Diagnosis
NiV can be diagnosed during illness or after recovery. Different tests are available to diagnose
NiV infection. During the early stages, laboratory tests such as real-time polymerase chain
reaction (RT-PCR) using swabs from the throat and nasal, cerebrospinal fluid, urine, and blood
collected for the test.
At later stages and after recovery of the disease, an enzyme-linked immunosorbent assay (ELISA)
is done for antibody determination. Other tests such as polymerase chain reaction (PCR) assay,
Seroneutralization (plaque reduction neutralization test (PRNT))and virus isolation by cell culture
were also conducted for detection.
Handling and processing specimens require suitably equipped laboratories under maximum
biological containment conditions and well-trained staff for collecting samples.
10. Treatment
Currently, no approved treatment regimens are available for Nipah virus (NiV)
infection. WHO has identified Nipah as a priority disease for the WHO
Research and Development Blueprint in the 2018 annual review. Treatment is
limited to intensive supportive care, including rest, hydration, and treatment
of symptoms as they occur.
However, a few immunotherapeutic treatments (monoclonal antibody
therapies) are currently under development and evaluation for treating NiV
infections.
1. Ribavirin: During the NiV outbreak in Malaysia in 1998/99, ribavirin was given empirically to
treat 140 patients. The trial is non-randomized. Mortality was lower in the treated group
(32%) compared to the controls (54%), corresponding to a 36% reduction.
11. 2. Convalescent plasma has not been investigated clinically during outbreaks of NiV infections.
3. Monoclonal antibodies targeting the surface glycoproteins showed efficacy against both
Hendra and Nipah viruses as pre-and post-exposure prophylaxis on animal models for the
experiment.
Monoclonal Antibodies m102.4 have potent neutralizing and cross-neutralizing activity
against both Hendra virus and Nipah viruses has been demonstrated in both ferrets and
NHPs infected with either Hendra or Nipah viruses.
In humans, m102.4 has been used in Australia (10 people exposed to Hendra virus) at high-
dose therapy under compassionate protocol where all survived with no associated adverse
events.
The double-blind, placebo-controlled, single-center, and dose-escalation phase 1 trial of
m102.4 was all implemented in Australia in 2015-16. Dosing was well tolerated and safe,
displayed linear pharmacokinetics, and showed no evidence of an immunogenic response.
13. In areas where Nipah virus (NiV) outbreaks have occurred people should:
Practice regular handwashing with soap and water
Avoid contact with sick bats and pigs and their geographic location
Avoid areas where bats are known to roost
Avoid contaminated fruits and vegetables by bats
Avoid contact with the body fluids of Niv infected
Using face mask and Personal Protective Equipment (PPE) to avoid infection while working in a
healthcare setting where infection is suspected or detected.
Taking proper measures of standard infection control practices and proper barrier nursing
techniques are important in preventing hospital-acquired infections (nosocomial transmission) in
settings where a patient has confirmed or suspected of NiV infection.
In addition to the above steps, it will be critical for scientists, researchers, and communities at risk to
continue learning about NiV to prevent future outbreaks.
14. Broader prevention efforts include:
Increasing surveillance of animals and people in areas where NiV is known to exist.
Increasing research on the ecology of fruit bats to understand where they live and how they
spread the virus to other animals and people.
Evaluation of novel technologies or methods to minimize spread of the virus within bat
populations.
Improving tools to detect the virus early in communities and livestock.
Reinforcing protocols for healthcare settings on standard infection control practices to
prevent person-to-person spread.
15. Public health educational messages should focus on:
Reducing the risk of bat-to-human transmission.
Reducing the risk of animal-to-human transmission.
Reducing the risk of human-to-human transmission.
16. Pteropus Bats Presence and Nipah Virus Outbreaks
Pteropus Bats Presence and Previous Nipah Virus Infections:
Asia, South Pacific, and Australia Region
Countries with previously reported Nipah virus outbreaks in
people:
Bangladesh, India, Malaysia, Philippines, Singapore
Countries where Pteropus bat species are known or likely
present:
Australia, Bangladesh, Bhutan, Brunei, Burma, Cambodia,
China, Guam, India, Indonesia, Laos, Mariana Islands, Malaysia,
Nepal, Pakistan, Palau, Papua New Guinea, Philippines,
Singapore, Sri Lanka, Taiwan, Thailand, Timor-Leste, Vietnam
This map shows areas where outbreaks of Nipah virus (NiV) in
people have already occurred, including cases of illness and
death. It also highlights where multiple species of bats of the
genus Pteropus, which can spread NiV, are known or are
thought to live in the Asia, South Pacific, and Australia
region. Pteropus bats are also found in locations in Asia and
Africa that are not shown here.
17. References:
WHO's work on Nipah virus disease
R&D Blueprint and Nipah virus
https://www.who.int/news-room/fact-sheets/detail/nipah-virus
https://www.cdc.gov/vhf/nipah/index.html